Pediatric dilated cardiomyopathy and the progression to heart failure: mechanisms and interventions focusing on the “gene-inflammation-metabolism” axis
A pediatric-specific triaxial framework is presented that unifies known DCM pathways into a single actionable model for precision risk stratification and targeted therapy, and supports the development of novel biomarkers, multi-dimensional risk stratification strategies, and targeted interventions.